Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review.

Prof Jane Speight Pratik ChoudharyEmma G WilmotChristel HendrieckxHannah FordeWai Yee CheungThomas S J CrabtreeBekki MillarGemma D Traviss-TurnerAndrew HillRamzi A Ajjan

Published in: Diabetic medicine : a journal of the British Diabetic Association (2022)

PROs are usually assessed as secondary outcomes in glycaemic technology studies. Hypoglycaemia-specific and diabetes-specific, but not generic, PROs show the benefits of glycaemic technologies, and deserve a more central role in future studies as well as routine clinical care.

Keyphrases

type diabetes
glycemic control
healthcare
cardiovascular disease
case control
palliative care
current status
insulin resistance
metabolic syndrome
skeletal muscle
pain management
chronic pain